Ipamorelin Benefits Reported in Research

The gist

The ipamorelin benefits reported in research are, first and most concretely, about bone. In rats, ipamorelin made leg bones grow longer in a clean dose-response, raised the mineral content of bone, and partly rebuilt bone that steroids had broken down. Those are the strongest, best-measured outcomes in its file.

The rest follows from a clean pulse of growth hormone — the hormone that drives much of childhood growth and adult repair — without the cortisol or prolactin spillover older peptides caused. Reported downstream effects include recovery and body-composition shifts, but those are softer. Important caveat: every benefit on this page is from animals or community report, not human trials. The one human efficacy trial — for bowel recovery — failed ^[5]. Read these as a research record, not promises.

Bone lengthening, dose by dose

The clearest benefit signal is longitudinal bone growth. Ipamorelin at 18, 90, and 450 microg/day SC (split three times daily, 15 days) raised the bone growth rate of adult female rats from 42 microm/day on vehicle to 44, 50, and 52 microm/day — a clean, dose-dependent climb ^[1]. (Longitudinal growth = lengthening at the growth plate, the cartilage zone where bones extend.)

What makes it interesting: total IGF-1, IGF binding proteins, and bone turnover markers did not change ^[1]. The bone grew without a measurable rise in the usual systemic growth-hormone messenger — pointing to a partly local, pulse-driven effect rather than a flood of circulating IGF-1.

More mineral in the bone

Ipamorelin also raised how much mineral bone holds. At 0.5 mg/kg/day, delivered continuously by an implanted osmotic minipump for 12 weeks, it increased total tibial and vertebral bone mineral content (by DXA scan) in adult female rats versus vehicle ^[2]. (DXA = the same dual-energy X-ray scan used to measure human bone density.)

The nuance: cortical volumetric bone mineral density did not change ^[2]. So the gain came from larger bone dimensions, not denser bone material — the skeleton got bigger, not harder. Honest framing matters here: "more mineral content" and "denser bone" are not the same claim, and the study supports the first, not the second.

Holding bone against steroids

Glucocorticoid steroids strip bone. Ipamorelin pushed back. At 100 microg/kg SC three times daily for 3 months, given alongside methylprednisolone, it raised the periosteal bone formation rate roughly four-fold versus the steroid alone, and increased maximum tetanic muscle tension ^[3]. (Periosteal = the outer surface layer where bone is laid down.)

A supporting study explains why this can work: methylprednisolone did not blunt ipamorelin's acute growth-hormone release, and the combination raised IGF-1 and recovered body weight versus steroid alone ^[9]. The growth-hormone pulse survives steroid suppression — the mechanistic basis for the bone rescue. Still rats, still preclinical.

The clean GH pulse behind it

Every bone benefit traces to one thing: a selective growth-hormone pulse. Ipamorelin released growth hormone as potently as GHRP-6 (pig ED50 2.3 vs 3.9 nmol/kg) but, unlike GHRP-6, did not raise ACTH or cortisol even past 200-fold its growth-hormone ED50 ^[4]. That selectivity is the headline benefit researchers cared about: the upside of growth-hormone stimulation without the stress-hormone cost. It is also why ipamorelin keeps getting paired with GHRH analogs on the ipamorelin benefits of a two-pathway approach — covered on the research page.

Body composition and recovery

Beyond bone, the reported benefits get softer. In mice, two weeks of ipamorelin raised fat-pad weight and leptin — but it also raised those independently of growth hormone, so the body-composition story is not a simple "lean gains" claim ^[17]. Community accounts describe faster recovery and a gradually leaner look over weeks, which sit on the Ipamorelin effects page as anecdote, not measured outcomes. The honest summary: bone is the proven-in-animals benefit; the physique and recovery claims are real reports but unproven evidence.